Comprehensive genomic profiling of histologic subtypes of urethral carcinomas

CONCLUSIONS: Comprehensive genomic profiling reveals GA that may be predictive of both targeted and immunotherapy benefit in patients with advanced UrthCa and that could potentially be used in future adjuvant, neoadjuvant, and metastatic disease trials.PMID:34215504 | DOI:10.1016/j.urolonc.2020.12.021
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research